A world-class team of researchers, co-led by UCSF’s Allan Balmain, and including Kim Rhoads and Luke Gilbert, has been selected to receive a $25M Cancer Grand Challenges award to investigate the very early stages of cancer development. [read more]

Nynikka Palmer, DrPH, MPH named a 2022 recipient of the UCSF Mid-Career Development Program for Research Faculty. Learn more.

Ana Velázquez Mañana, MD named a member of the 2022 class of John A. Watson Faculty Scholars and a recipient of the Dean’s Diversity Fund Award.

Keith Yamamoto, PhD elected president of the American Association for the Advancement of Science (AAAS). Learn more.

Janelle Smith Hernandez, MHA awarded the Chancellor Award for Exceptional Management at the 2022 UCSF Founders Day Awards Celebration.

Geoffrey Buckle, MPH, MD awarded a Global Oncology Young Investigator Award by Conquer Cancer, the ASCO Foundation. Learn more.

Nina Shah, MD and Bridget Keenan, MD, PhD nominated as 2022 Women Leaders in Oncology. Learn more.

Kumar A, Mohamed E, Tong S, Chen K, Mukherjee J, Lim Y, Wong CM, Boosalis Z, Shai A, Pieper RO, Gupta N, Perry A, Bollen AW, Molinaro AM, Solomon DA, Shieh JTC, Phillips JJ. CXCL14 promotes a robust brain tumor-associated immune response in glioma. Clin Cancer Res. 2022 May 5:clincanres.2830.2021.

Tsai KK, Huang SS, Northey JJ, Liao WY, Hsu CC, Cheng LH, Werner ME, Chuu CP, Chatterjee C, Lakins JN, Weaver VM. Screening of organoids derived from patients with breast cancer implicates the repressor NCOR2 in cytotoxic stress response and antitumor immunity. Nat Cancer. 2022 May 26.

Kerlikowske K, Su YR, Sprague BL, Tosteson ANA, Buist DSM, Onega T, Henderson LM, Alsheik N, Bissell MCS, O'Meara ES, Lee CI, Miglioretti DL. Association of Screening With Digital Breast Tomosynthesis vs Digital Mammography With Risk of Interval Invasive and Advanced Breast Cancer. JAMA. 2022 Jun 14;327(22):2220-2230. 

Kumar A, Mohamed E, Tong S, Chen K, Mukherjee J, Lim Y, Wong CM, Boosalis Z, Shai A, Pieper RO, Gupta N, Perry A, Bollen AW, Molinaro AM, Solomon DA, Shieh JTC, Phillips JJ. CXCL14 promotes a robust brain tumor-associated immune response in glioma. Clin Cancer Res. 2022 May 5:clincanres.2830.2021. 

Participants will be interviewed by a UCSF faculty member, nurse practitioner, or physician assistant. Each interview is 1 hour and includes 15-20 minutes of feedback. Apply here. Open to all HDFCCC staff. If you are interested in being an interviewer, email Jennifer Seuferer.

Two grants will be awarded (up to $1500 each) to postdocs who do not otherwise have the means to attend a desired research meeting. For one of the awards, priority will be given to applicants from historically disenfranchised racial and ethnic groups that are under-represented in health sciences or from economically disadvantaged backgrounds. Open to postdocs in HDFCCC member labs only. Learn more and apply.

June 16-22: National Black Family Cancer Awareness Week

Please join us and help raise awareness for those at greatest risk! Follow along on social media with #BlackFamCan.

June 17: Cancer Center Friday Seminar Series

Benjamin Deneen, PhD (Baylor College of Medicine) will present, "The Neuroscience of Glioma."

June 27: Benioff Initiative for Prostate Cancer Research (BIPCR) Speaker Series

Featuring Adam Sowalsky, PhD, Head of the Prostate Cancer Genetics Section, National Cancer Institute (NCI).

June 28-30: Precision Medicine World Conference

Featuring 25+ UCSF speakers, this in-person conference will highlight precision medicine approaches in emerging therapeutics, the clinic, COVID-19, data sciences, and more.

June 30: The Inaugural UCSF Central Nervous System Metastasis Symposium

A hybrid event exploring research and treatment related to central nervous system metastatic disease.